DB:7AT

Stock Analysis Report

Executive Summary

Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark.


Snowflake Analysis

Reasonable growth potential with imperfect balance sheet.


Similar Companies

Share Price & News

How has Attendo's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 7AT has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-4.4%

7AT

-2.6%

DE Healthcare

-5.7%

DE Market


1 Year Return

-19.5%

7AT

-0.3%

DE Healthcare

6.1%

DE Market

Return vs Industry: 7AT underperformed the German Healthcare industry which returned -0.3% over the past year.

Return vs Market: 7AT underperformed the German Market which returned 6.1% over the past year.


Shareholder returns

7ATIndustryMarket
7 Day-4.4%-2.6%-5.7%
30 Day-4.7%-1.8%-5.7%
90 Day4.0%0.2%-3.6%
1 Year-18.5%-19.5%1.5%-0.3%9.3%6.1%
3 Year-45.6%-47.9%-23.4%-26.2%8.9%-0.7%
5 Yearn/a-0.3%-5.8%13.6%-2.0%

Price Volatility Vs. Market

How volatile is Attendo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Attendo undervalued compared to its fair value and its price relative to the market?

100.1x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 7AT (€4.68) is trading above our estimate of fair value (€1.63)

Significantly Below Fair Value: 7AT is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 7AT is poor value based on its PE Ratio (100.1x) compared to the Healthcare industry average (36.9x).

PE vs Market: 7AT is poor value based on its PE Ratio (100.1x) compared to the German market (20.2x).


Price to Earnings Growth Ratio

PEG Ratio: 7AT is poor value based on its PEG Ratio (1.7x)


Price to Book Ratio

PB vs Industry: 7AT is good value based on its PB Ratio (1.4x) compared to the DE Healthcare industry average (1.5x).


Next Steps

Future Growth

How is Attendo forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

58.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7AT's forecast earnings growth (58.5% per year) is above the savings rate (-0.4%).

Earnings vs Market: 7AT's earnings (58.5% per year) are forecast to grow faster than the German market (13% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 7AT's revenue (6.4% per year) is forecast to grow faster than the German market (5.1% per year).

High Growth Revenue: 7AT's revenue (6.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7AT's Return on Equity is forecast to be low in 3 years time (6%).


Next Steps

Past Performance

How has Attendo performed over the past 5 years?

-8.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 7AT has high quality earnings.

Growing Profit Margin: 7AT's current net profit margins (0.7%) are lower than last year (2.9%).


Past Earnings Growth Analysis

Earnings Trend: 7AT's earnings have declined by -8.9% per year over the past 5 years.

Accelerating Growth: 7AT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 7AT had negative earnings growth (-74.8%) over the past year, making it difficult to compare to the Healthcare industry average (6.2%).


Return on Equity

High ROE: 7AT's Return on Equity (1.4%) is considered low.


Next Steps

Financial Health

How is Attendo's financial position?


Financial Position Analysis

Short Term Liabilities: 7AT's short term assets (SEK2.2B) do not cover its short term liabilities (SEK2.7B).

Long Term Liabilities: 7AT's short term assets (SEK2.2B) do not cover its long term liabilities (SEK11.8B).


Debt to Equity History and Analysis

Debt Level: 7AT's debt to equity ratio (48.7%) is considered high.

Reducing Debt: 7AT's debt to equity ratio has reduced from 205.6% to 48.7% over the past 5 years.

Debt Coverage: 7AT's debt is well covered by operating cash flow (63.4%).

Interest Coverage: 7AT's interest payments on its debt are not well covered by EBIT (1.3x coverage).


Balance Sheet

Inventory Level: 7AT has a high level of physical assets or inventory.

Debt Coverage by Assets: 7AT's debt is not covered by short term assets (assets are 0.8x debt).


Next Steps

Dividend

What is Attendo's current dividend yield, its reliability and sustainability?

1.11%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 7AT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 7AT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 7AT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 7AT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 7AT is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 7AT's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Martin Tivéus (49yo)

1.4yrs

Tenure

kr13,229,000

Compensation

Mr. Martin Folke Tivéus has been the Chief Executive Officer at Attendo AB (publ) since September, 2018 and has been its President since 2018. Mr. Tivéus is Director of Telia Company AB since March 2018. H ...


CEO Compensation Analysis

Compensation vs Market: Martin's total compensation ($USD10.89K) is below average for companies of similar size in the German market ($USD1.20M).

Compensation vs Earnings: Insufficient data to compare Martin's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Martin Tivéus
CEO & President1.4yrskr13.23mno data
Fredrik Lagercrantz
Chief Financial Officer1.9yrsno datano data
Andreas Koch
Communications & IR Director3.8yrsno data0.015% SEK119.4k
Stefan Svanström
Head of Community Communications0yrsno datano data
Rebecca Birck
Head of Corporate Control0yrsno datano data

1.9yrs

Average Tenure

42yo

Average Age

Experienced Management: 7AT's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Anssi Jyrki Soila
Independent Director13.1yrskr410.00k0.78% SEK6.1m
Anitra Steen
Independent Director3.8yrskr335.00k0.0068% SEK53.3k
Ulf Lundahl
Chairman of the Board2.8yrskr1.03m0.012% SEK97.9k
Alf Göransson
Independent Director1.8yrskr335.00kno data
Arja Pohjamäki
Employee Representative Director0yrsno data0.000040% SEK315.0
Catarina Fagerholm
Independent Director3.8yrskr485.00k0.0062% SEK49.0k
Tobias Lönnevall
Independent Director3.8yrskr660.00k0.0037% SEK29.4k
Marco Donoso
Alternate Representative Director3.1yrsno datano data
Robin Filipson
Director0yrsno datano data
Faya Lahdou
Director0yrsno datano data

3.8yrs

Average Tenure

63yo

Average Age

Experienced Board: 7AT's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 7AT insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Attendo AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Attendo AB (publ)
  • Ticker: 7AT
  • Exchange: DB
  • Founded: 1985
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: kr8.326b
  • Listing Market Cap: kr787.378m
  • Shares outstanding: 160.89m
  • Website: https://www.attendo.com

Number of Employees


Location

  • Attendo AB (publ)
  • Vendevägen 85
  • Danderyd
  • Stockholm County
  • 182 91
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ATTOM (OMX Nordic Exchange Stockholm)YesClass A SharesSESEKNov 2015
7ATDB (Deutsche Boerse AG)YesClass A SharesDEEURNov 2015
ATTSBATS-CHIXE (BATS 'Chi-X Europe')YesClass A SharesGBSEKNov 2015
0RCYLSE (London Stock Exchange)YesClass A SharesGBSEKNov 2015

Biography

Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark. The company offers care services for older people in nursing homes and home care. It also provides care services for people with disabilities; homes for children with special needs; consultant supported family home care services; crisis and acute accommodations; substance abuse care services; and care homes for people with neuropsychiatric conditions. The company was founded in 1985 and is headquartered in Danderyd, Sweden. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/25 23:11
End of Day Share Price2020/02/25 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.